Furman-2021-Augmenting Frontal Dopamine Tone E.pdf Part 2

Importantly, context-first (CF) and context-last (CL) trials, irrespective of whether they are selective or global, are not distinguished by other factors, such as conflict during response selection. 

The reaction selection period refers to the thinking and decision-making time we need when facing different choices. Memory is our brain's ability to store and retrieve information from past experiences and learning. The two may not seem to have much connection, but they are closely related.

First, whether the response selection period is short or long often depends on our proficiency in a task and the amount of background knowledge we have. When we are more familiar with a certain task, we will find that the response selection period when performing this task is shorter. This is because our brains already store relevant information in long-term memory and can retrieve and apply this information quickly. On the contrary, when we face something new and unfamiliar, we need longer thinking time to decide because we need to repeatedly deliberate and compare in short-term memory. This also affects our memory, as we need to store new information in short-term memory and then convert it into long-term memory, which can take longer and more energy.

Secondly, when we work hard to improve our memory, it also indirectly affects our response selection period. For example, when we actively increase our background knowledge and memory abilities by reading books, attending courses, and performing memory training, we will find that when faced with new tasks, the response selection period is shorter because we can more quickly Retrieve relevant information from long-term memory. This also strengthens our confidence and improves our ability to control our cognitive and emotional states.

In summary, there is a close relationship between the response selection period and memory. Although it may take us longer to make decisions when faced with new things, by working on improving our memory, we can improve our cognitive efficiency and accuracy, making it easier for us to make the right choices. Therefore, we encourage everyone to actively learn, stay curious, and explore further, which will help improve our response selection period and memory, making us a better version of ourselves. It can be seen that we need to improve memory, and Cistanche deserticola can significantly improve memory, because Cistanche deserticola has antioxidant, anti-inflammatory, and anti-aging effects, which can help reduce oxidation and inflammatory reactions in the brain, thereby protecting the health of the nervous system. In addition, Cistanche deserticola can also promote the growth and repair of nerve cells, thus enhancing the connectivity and function of neural networks. These effects can help improve memory, learning, and thinking speed, and may also prevent the development of cognitive dysfunction and neurodegenerative diseases.

Click Know to improve short-term memory

For example, the CF-G and CL-G conditions both include a correct response that contains the symbol and the letter presented during the trial. Additionally, as noted previously some global trials contain the same item in both the target and foil responses to ensure that subjects cannot simply focus on one, rather than both, items. Behavioral Analysis. 

In keeping with previous studies (Chatham & Badre, 2013; Chatham et al., 2014), we focused primarily on response time (RT), rather than accuracy. Accuracy, as a binary (right/wrong) outcome measure, is relatively insensitive to changes in task efficiency. While true maintenance and gating failures could be reflected in changes in accuracy, inefficiencies would not; instead, responses would simply be slowed. 

To address the hypothesis that tolcapone should preferentially reduce the number of inefficient trials, even if the proportion of ultimately correct trials remains unchanged, we used a measure sensitive to the distribution of responses across trials, and in particular to the number of inefficient (long RT) responses. Of note, while RT reflects a combination of factors, including early visual processing and motor preparation, early visual processing demands are matched across the task, and our previous work has confirmed that tolcapone does not significantly speed motor responses (Furman et al., 2020; Kayser et al., 2012; Kayser et al., 2015). 

Thus, early visual processing and motor preparation demands should not distinguish task conditions based on RT-related measures. All behavioral data were preprocessed before analysis. Because the primary focus was on reaction times, data that impacted stable RT measurements were removed. As noted previously, 3 of the 11 excluded subjects were eliminated for failing to respond with greater than chance accuracy across all trials. 

For each of the 49 retained subjects, the first 10 trials of each session were removed from all analyses; in addition, all incorrect trials and any trials with RTs greater than 5 standard deviations outside of the mean RT for that subject were excluded from analysis of RT (Chatham & Badre, 2013; Chatham et al., 2014). This outlier threshold was chosen to balance two concerns: the desire to avoid censoring inefficient RTs, but also the goal of avoiding very long RTs confounded by factors unrelated to the task (e.g. due to failure to attend to the computer screen). 

Across all subjects, only 1 trial was removed for falling outside the desired RT range. A linear mixed-effects model was used to address tolcapone-related changes in mean RT. The model was additionally constructed to test for tolcapone-related effects on the RT distribution (see below) for each task condition (Chatham et al., 2014), as measuring the mean RT does not address potentially more subtle changes in the distribution of RTs across experimental manipulations. Conceptually, changes in the efficiency of maintenance or gating may not be reflected in trials for which these processes are already optimized. 

Trials with very fast RTs, for example, may reflect strong maintenance and gating processes for which any manipulation may have little observable beneficial effect. In contrast, trials with very slow RTs may reflect inefficient maintenance and gating processes that might improve with the drug. Similarly, if tolcapone worsened the efficiency of gating or maintenance, these effects might be most visible at the fast end of the RT distribution. 

To measure any such effects, we took an approach utilized previously with this task (Chatham et al., 2014) to divide the RT data for each participant and condition into 10 deciles, sorted by RT from fastest to slowest, and to use the mean RT values per decile as the dependent variable in our analysis. This approach permitted us to evaluate drug-related changes in slope across the deciles ("RT slope"), as well as the mean change in RT. 

In the model, factors included drug (tolcapone or placebo; treatment coded), task condition (CF-S, CF-G, CL-S, or CL-G; sum coded), and decile (1-10; ordinal), as well as all interactions. To account for the potential nonlinear effect of tolcapone on RT distribution, a comparable set of interaction terms was included for decile 2 ("decile squared"). Finally, interactions with drug session order (drug first or drug last; sum coded) were included as a control measure. Initially, a maximal random effects structure was constructed to minimize Type I errors (Barr, Levy, Scheepers, & Tily, 2013). 

Random effects included the intercept of the subject, as well as the slopes of the drug, task condition, and decile/decile 2 and their interactions, and the correlation between random slopes and subject intercept. This model failed to converge; thus, following the protocol outlined in (Bates, Kliegl, Vasishth, & Baayen, 2015), we removed the correlation between random slopes and intercepts. F-tests were computed for fixed effects using the Satterthwaite method for approximating degrees of freedom. Analyses were carried out using the "lme4" (Bates et al., 2015) and "afex" (Singmann et al., 2018) libraries in R (R Core Team, 2017). 

Estimation of marginal means and trends, as well as follow-up z-tests, were conducted using the "means" package (Lenth, 2018). For completeness, trial-wise accuracy was also analyzed. 

A binomial generalized mixed effects model included the fixed factors drug, task condition, and their interaction. After dropping terms to enable convergence and avoid singular fit, the final random effects structure included random intercepts for the subject and random slopes of the drug within the subject. Likelihood-ratio tests were used to determine the significance of fixed effects terms.

MRI Parameters. MRI scanning was conducted on a Siemens MAGNETOM Trio 3T MR Scanner at the Henry H. Wheeler, Jr. Brain Imaging Center at the University of California, Berkeley.

Anatomical images consisted of 160 slices acquired using a T1-weighted MP-RAGE protocol (TR = 2300 ms, TE = 2.98 ms, FOV = 256 mm, matrix size = 256 x 256, voxel size = 1 mm3 ). Resting-state functional images were obtained while subjects were lying quietly with eyes open, and consisted of 35 slices acquired with a gradient echoplanar imaging protocol (TR = 1900 ms, TE = 24 ms, FOV = 225 mm, matrix size = 96 x 96, voxel size = 3.0 mm x 3.0 mm x 3.5 mm). fMRI preprocessing. fMRI preprocessing was performed using both the AFNI (http://afni.nimh.nih.gov) and FSL (http://www.fmrib.ox.ac.uk/fsl/) software packages. Resting-state functional images were converted to 4D NIfTI format and corrected for slice-timing offsets.
Motion correction was carried out using the AFNI program 3dvolreg, with the reference volume set to the mean image. Co-registration with the anatomical scan was performed using the AFNI program 3dAllineate, and anatomical images were normalized to a standard volume (MNI_N27) using the FSL program first. The same normalization parameters were later applied to native-space statistical maps to generate group statistical maps. 

Resting state connectivity analysis. Resting-state data were smoothed by a 5mm FWHM Gaussian kernel before temporal bandpass filtering between 0.009 Hz and 0.08 Hz to reduce the influence of cardiac and respiratory artifacts (Fox et al., 2005). Movement parameters and the white matter and ventricular time series, but not the global mean signal, were included as regressors of no interest during preprocessing, independently of the subsequent connectivity analyses. Regions of interest (ROIs) within the lateral prefrontal cortex were then selected, based on (a) their increased activity and central role in this and related tasks (Badre, Kayser, & D'Esposito, 2010; Chatham et al., 2014), and (b) the hypothesis that on tolcapone these regions, particularly those more proximate to the motor response, would demonstrate increased connectivity with visual areas in the posterior cortex. 

Specifically, these regions were located in the left and right dorsal premotor cortex (PMd, with MNI, coordinates ±30, -12, 66) and left and right pre-premotor cortex (pPMd, with MNI, coordinates ±36, 8, 34) (Badre et al., 2010; Chatham et al., 2014). 

Each ROI was defined by a set of MNI coordinates that formed the center for a sphere with an 8mm radius. Time courses defined by averaging across voxels in each of these regions were then correlated separately with all other voxels in the brain, and correlation coefficients were Fisher-transformed to allow for the application of parametric statistical tests. 

The resulting individual brain maps were normalized to the MNI template before the application of group statistics. To examine the relationship between drug effects on behavioral performance and drug-related changes in functional connectivity, we first calculated the difference between placebo and tolcapone connectivity maps for each participant and seed region, and then computed the correlation between these differences maps and the random effect variables corresponding to subject-wise drug decile effect ("overall RT slope") and drug x decile x CF-G × effect (computed as the additive effect of "drug decile" and "drug decile x CF-G"; × × hereafter referred to as "RT slope for the CF-G condition") estimated in our behavioral model (see Behavioral Analysis). 

Map-wise significance (p < 0.001, corrected for multiple comparisons) was determined by applying a cluster-size correction (20 voxels) derived from the AFNI programs 3dFWHMx and 3dClustSim to data initially thresholded at a value of p < 0.0001, uncorrected.

Results: 49 subjects completed a hierarchical working memory task in which they were required to use context cues, indicated by numbers, to recall symbols and/or letters across the duration of a trial (Figure 1A-E). Consistent with prior work (Chatham et al., 2014), four task conditions were evaluated: context first, selective (CF-S); context first, global (CF-G); context last, selective (CL-S); and context last, global (CL-G). 

Notably, each of these conditions places differential strategic demands on input gating, output gating, and maintenance (Methods, and Figure 1F). For these conditions, we evaluated both the mean RTs and the change in the distribution of RTs across ten ordered deciles for each task condition (Chatham et al., 2014). This "RT slope" value better reflects the distribution of reaction times for each condition; specifically, in distinction from mean RT or accuracy, it addresses the possibility that enhancing cortical dopamine tone may not improve maintenance across all trials, but instead may preferentially improve inefficient maintenance, or disrupt efficient maintenance, across trial subtypes (see Methods). 

Though accuracy varied by task condition (  2 (3)=174.23, p<0.0001), there was no significant effect of drug (  2 (1)=0.03, p=0.87), nor interaction of drug and condition (  2 (3)=1.83, p=0.61), on task accuracy (see Table 1). Our analysis of RT revealed a significant main effect of task condition on RT (F[3,114.79]=420.87, p < 0.0001), consistent with previous work using this paradigm (Chatham et al., 2014). Interactions of condition x decile (F[3,80.1]=26.19, p < 0.0001) and of condition x decile 2 (F[3,57.87]=17.07, p < 0.0001), and the hypothesized 3-way interactions of condition x decile x drug (F[3,59.65]=3.50, p = 0.02), and of condition x decile 2 x drug (F[3,83.22]=3.05, p = 0.03) were also identified (see Table 1). 

Of note, these 3-way interactions persisted despite a 4-way interaction of condition x decile x drug x session order (F[3,59.65]=2.96, p=0.04; the comparable term "condition x decile 2 x drug x session order" was not significant, F[3,83.22]=1.59, p=0.2). There was no simple effect of drug on RT (F[1,49.68]=0.03, p=0.86), and the interactions of drug x decile (F[1,47.36]=0.34, p = 0.56), drug x decile 2 (F[1,63.41]=1.36, p = 0.25), and drug x condition (F[3,76.84] = 0.76, p = 0.52) were all insignificant. As expected, the simple effects of decile (F[1,58.43]=1078.76, p < 0.0001) and decile 2 (F[1,44.22]=485.78, p < 0.0001) were significant, but these effects are a direct consequence of the analysis design and were not explored further. 

Estimated marginal means for condition, and condition-specific trends across decile and decile 2, for both placebo and tolcapone sessions are provided in Table 1. Follow-up z-tests determined that the 3-way interaction of interest (drug x condition x decile) was driven, at least in part, by a significant effect of tolcapone (vs. placebo) on RT slope for CF-G trials (trend estimate = -6.2, SE = 2.7, z = -2.3, p = 0.02). 

This effect on RT slope was also evident in the CF-G condition in the raw data (Figure 2B) and consistent with our hypothesis that the effect of tolcapone should be most evident when maintenance demands are high and (output) gating demands are low (Figure 1F). 

In addition, because optimized behavioral responses should have shorter RTs, this reduction in RT slope is consistent with the hypothesis that tolcapone should improve the efficiency of maintenance processes such that the proportion of trials with longer RTs should decrease.

For more information:1950477648nn@gmail.com